No results found.

No results found.

Home
News
- News
Entertainment
- Funny & Gags
- Gossip
Business
- Business
Sports
- Sports
Science & Tech
- Tech
- Science

News
- - News
Entertainment
- - Funny & Gags
  - Gossip
Business
- - Business
Sports
- - Sports
Science & Tech
- - Tech
  - Science

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India

News / News 7 years ago 585 Views comments

Osimertinib is an oral anti-cancer drug for management of lung cancer.

Source:
Moneycontrol Latest News

facebook
twitter
Whatsapp
google+
linkedin
email

Paid Prime Membership on Primevideo.com

Previous post

Westlife Development#39;s board meeting on August 01, 2017

Next post

Stay with winners! Top 12 wealth creators across sectors for a period of 2-3 years

Comments

Related Posts

Week Ahead: Earnings kick off, as IPO mania continues; top factors that could drive market

News / News - 7 years ago

Hafiz Saeed trying to hide his blood-stained hands behind ballot ink: India

News / News - 7 years ago

Paytm invests in loyalty program and analytics startup MobiQuest

News / News - 7 years ago

Telangana weighs incentive package to woo EV players

News / News - 7 years ago

Supreme Court rejects pleas to hear Ayodhya title cases post 2019 polls

News / News - 7 years ago

All inter-religious marriages not #39;love jihad#39;: Kerala HC

News / News - 7 years ago

RIVER Collection launch: Latest styles from your favourite designers | Made for Amazon | Up to 20% off - Launching on 1st

Follow @truearacom

TrueAra

Pages

Popular Tweets
Privacy
Terms Of Use

Categories

Living
Movies

Follow us

Copyright 2016-2017 Content Aggregator All rights reserved.